PA
XFOR icon

Perceptive Advisors’s X4 Pharmaceuticals XFOR Stock Holding History

Perceptive Advisors’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.8M Buy
6,737,648
+423,196
+7% +$1.59M 0.55% 39
2025
Q4 		$25.3M Buy
+6,314,452
New +$22.9M 0.46% 54
2024
Q4 		– Sell
-118,182
Closed -$2.37M – 126
2024
Q3 		$2.37M Hold
118,182
– – 0.05% 91
2024
Q2 		$2.06M Hold
118,182
– – 0.05% 94
2024
Q1 		$4.93M Hold
118,182
– – 0.09% 87
2023
Q4 		$2.97M Hold
118,182
– – 0.07% 84
2023
Q3 		$3.86M Hold
118,182
– – 0.13% 74
2023
Q2 		$6.88M Sell
118,182
-33,333
-22% -$1.71M 0.2% 71
2023
Q1 		$3.95M Buy
+151,515
New +$4.44M 0.12% 79

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return